Donor-derived cell-free DNA (dd-cfDNA) testing

Type: diagnostic

Status: FDA Approved

Developer: Natera (Prospera), CareDx (AlloSure)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026